Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

China Pharma Holdings (CPHI) Assets Average: 2009-2025

Historic Assets Average for China Pharma Holdings (CPHI) over the last 16 years, with Sep 2025 value amounting to $14.8 million.

  • China Pharma Holdings' Assets Average rose 6.65% to $14.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $14.8 million, marking a year-over-year increase of 6.65%. This contributed to the annual value of $15.7 million for FY2024, which is 8.46% down from last year.
  • China Pharma Holdings' Assets Average amounted to $14.8 million in Q3 2025, which was up 5.67% from $14.0 million recorded in Q2 2025.
  • China Pharma Holdings' Assets Average's 5-year high stood at $21.8 million during Q1 2022, with a 5-year trough of $13.9 million in Q3 2024.
  • In the last 3 years, China Pharma Holdings' Assets Average had a median value of $15.2 million in 2024 and averaged $15.3 million.
  • As far as peak fluctuations go, China Pharma Holdings' Assets Average grew by 6.66% in 2022, and later declined by 19.57% in 2023.
  • Quarterly analysis of 5 years shows China Pharma Holdings' Assets Average stood at $20.4 million in 2021, then declined by 16.76% to $17.0 million in 2022, then dropped by 6.37% to $15.9 million in 2023, then fell by 10.90% to $14.2 million in 2024, then rose by 6.65% to $14.8 million in 2025.
  • Its last three reported values are $14.8 million in Q3 2025, $14.0 million for Q2 2025, and $14.6 million during Q1 2025.